NEDD4L can degrade serine/threonine kinase 35 (STK35) by ubiquitination and then inhibit glycolysis, increasing the apoptosis of CRC cells by suppressing the Akt signaling pathway and modulating the chemoresistance of CRC cells (42). The gene discussed is AKT1; the disease is colorectal carcinoma.